Subsequent Categorisation Research Articles

Clinical phenotyping of children with nocturnal enuresis: A key classification to improve the approach

The literature shows that nocturnal enuresis is not an isolated phenomenon of urinary loss during sleep, but encompasses a set of systemic clinical manifestations that significantly influence children's quality of life and development. However, the understanding of the clinical and physiological relationship of these systemic manifestations remains a clinical challenge. The recognition of these manifestations and their subsequent categorisation, may provide better insights into integrated clinical manifestations, facilitating the understanding of pathophysiological mechanisms, and promote increased assertiveness in the assessment and the selection of appropriate therapies. The aim of this study is to develop a phenotyping model for children with nocturnal enuresis based on evidence. This study presents a clinical phenotyping model for children with nocturnal enuresis based on an analytical and methodological review of the literature, about nocturnal enuresis and its associated clinical manifestations. There was a bibliometric analysis carried out to better analyse outcomes. After reading and analysing the literature, the clinical manifestations were categorised into domains and submitted to the validation of an expert committee with extensive experience in their specific area of expertise. A visual representation of the categorised model was developed to make the phenotyping concept easily understandable to all professionals. The clinical manifestations related to nocturnal enuresis have been categorised according to frequency and relation found in the literature and validation by an expert committee and the development of the phenotyping model for children with nocturnal enuresis was completed. The present study developed an evidence-based phenotyping model for children with nocturnal enuresis.

The Concise Guide to PHARMACOLOGY 2023/24: Enzymes.

The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and about 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes almost 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.16176. In addition to this overview, in which are identified 'Other protein targets' which fall outside of the subsequent categorisation, there are six areas of focus: G protein-coupled receptors, ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2023, and supersedes data presented in the 2021/22, 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets.

The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and about 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes almost 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.16176. In addition to this overview, in which are identified 'Other protein targets' which fall outside of the subsequent categorisation, there are six areas of focus: G protein-coupled receptors, ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2023, and supersedes data presented in the 2021/22, 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

Overview of the Webinar on Maintaining Journal on the VAK List in 2023

The mandatory requirements for publications in the journals indexed in the Web of Science and Scopus are no longer applicable until the end of 2023. It has therefore become necessary to form new requirements for members of dissertation councils, including those with PhD and doctoral degrees, as well as for applicants for academic degrees defending dissertations in the form of a research report. In 2022, journals on the VAK List (List of the Higher Attestation Commission, HAC) were ranked, with subsequent categorisation. The journals now have account pages for the purpose of optimising and simplifying their monitoring, as well as their future ranking in 2023. On 6 March, 2023, the RIEPL together with the Russian Ministry of Science and Higher Education of Russia and the HAC, held a webinar dedicated to filling out the account on the Russian Scientific Journals website (https://rng.riep.ru/). The webinar addressed issues of registration, technical features of the portal, the algorithm for entering data on articles, and more. More than 1,500 people tuned into the webinar broadcast. The recording can be found at: https://www.youtube.com/watch?v=SzYm-o_Fmtw

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets.

The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.15537. In addition to this overview, in which are identified ‘Other protein targets’ which fall outside of the subsequent categorisation, there are six areas of focus: G protein‐coupled receptors, ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2021, and supersedes data presented in the 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

Access control of human resource records: case of the University of Cape Coast, Ghana

PurposeSecurity of human resource records is important because of their nature but they are not adequately managed. This study aims to investigate access control issues affecting the security and confidentiality of human resource records at the University of Cape Coast.Design/methodology/approachA qualitative approach was used to conduct the study. Purposive sampling was used to select staff at the Directorate of Human Resource, University of Cape Coast. A textual analysis was used in analysing responses to open-ended questions leading to the identification of patterns and their subsequent categorisation. An interview was also conducted.FindingsIt was found that effective strategies were implemented in controlling access to human resource information and records making them secure. The challenges identified were in two categories: existing and anticipated challenges. Suggestions to resolve the challenges were also enumerated.Originality/valueThis study highlights the need to ensure access to human resource records is controlled so that they are secured and kept confidential. This study contributes to knowledge in the broader context of information and records management and specifically, human resource information and records management. It also adds to the dearth of empirical studies that focus on the security and confidentiality of human resource records.

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets.

The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (http://www.guidetopharmacology.org/), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.14747. In addition to this overview, in which are identified Other protein targets which fall outside of the subsequent categorisation, there are six areas of focus: G protein‐coupled receptors, ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2019, and supersedes data presented in the 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

PP12 New ‘nature of call’ telephone screening tool, employed prior to nhs pathways triage, can accurately identify those later treated for out of hospital cardiac arrest: analysis of sensitivity and specificity using routine ambulance service data

BackgroundA new pre-triage emergency medical call screening tool, Nature of Call (NoC), has been introduced into UK ambulance services which employ the NHS Pathways (NHSP) triage system. Its current function is to provide a rapid sieve, differentiating between patients who may need treatment for Out-of-Hospital Cardiac Arrest (OHCA), and therefore require immediate ambulance dispatch, and all other calls, for which ambulance dispatch is withheld whilst further triage is undertaken.ObjectiveTo evaluate the accuracy of NoC in identifying patients with potentially treatable OHCA or peri-arrest conditions.MethodsStudy of diagnostic accuracy. The sample was a retrospective cohort of consecutive calls to a UK ambulance service, taken over a four-month period. Sensitivity and specificity were determined, comparing allocated priority dispositions with an OHCA Treatment Registry. Context was supplied by the evaluation of subsequent categorisation by NHSP. The accuracy of the combined NoC and NHSP allocations was also investigated.ResultsA total of 1 87 419 emergency calls were received. Of these, 71 373 were allocated both NoC and NHSP priority dispositions and were associated with electronic Patient Clinical Records. 590 (0.8%) of these patients received treatment for OHCA. NoC, sensitivity=77.6% (95% CI 74.1 to 80.8); specificity=86.9% (95% CI 86.6 to 87.1). NHSP, sensitivity=79.2% (95% CI 75.7 to 82.2); specificity=93.4% (93.2 to 93.6). NoC and NHSP combined, sensitivity=84.1% (95% CI 80.9 to 86.8); specificity=95.0% (95% CI 94.8 to 95.3).ConclusionsNoC and subsequent NHSP call categorisation each achieved relatively high sensitivity for the identification of treated OHCA, predicting similar groups of registry patients (although 6% were identified by NoC alone). Overall accuracy was enhanced when NoC and subsequent NHSP Results were combined. The unidentified group of treated OHCA patients (16%) present a challenge to the current dispatch system which relies on the early recognition of patients who may require treatment for OHCA.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview.

The Concise Guide to PHARMACOLOGY 2017/18 is the third in this series of biennial publications. This version provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13882/full. In addition to this overview, in which are identified ‘Other protein targets’ which fall outside of the subsequent categorisation, there are eight areas of focus: G protein‐coupled receptors, ligand‐gated ion channels, voltage‐gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2017, and supersedes data presented in the 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature Committee of the Union of Basic and Clinical Pharmacology (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

Associations with plant genetic engineering: A perception analysis of students’ hopes and fears

Public perceptions of plant genetic engineering are of increasing research interest. Although within the current debate on the cultivation of genetically modified plants many related ethical, political and economic issues need specific consideration, young students’ views on this socio-scientific issue are largely unexplored. Therefore, our current analysis focussed on perceptions of Bavarian tenth graders (N = 572) with regard to their hopes and fears in the context of plant genetic engineering. By applying a mixed-methods approach, students rated their individual hopes and fears on a 4-point Likert scale (quantitative part) and gave a written statement about their individual associations (qualitative part): Hereby, hopes scored much higher than fears (medium effect). The subsequent categorisation of qualitative data resulted in five categories for hopes and four categories for fears. Hopes were mainly associated with economic or ecological aspects as well as with the overall fight against world hunger. Fears dealt mainly with negative consequences on human health and the fate of the environment. Additionally, subjective and objective knowledge were analysed for their influence on students’ perceptions. Subjective knowledge had a significant influence on hopes, objective knowledge did not. This background information is relevant for the age-appropriate preparation of biology lessons: Hopes and fears need to be specifically addressed in order to optimise educational efforts and to support students to become responsible citizens.

Towards Finer Granularity in Metadata

In early 2010, the Austrian Academy of Sciences’ ICLTT instituted an experiment in selective metadata creation for a medium-sized collection (<100 million tokens) of digitised periodicals. The project has two main objectives: (a) assigning basic structures to previously digitised texts, so-called divisions in TEI nomenclature, thus creating a set of new digital objects, and (b) the subsequent categorisation of these texts with the purpose of being able to create thematically organised sub-corpora. An additional objective was to have metadata stored as TEI headers. Attempts at streamlining metadata creation are legion, in particular in the library community. Tools to do the job are often incorporated into workflow engines which consist of commercial products (such as docWORKS[e] and C-3) as well as free products such as Goobi, which incorporates the metadata creation tool RusDML, and the Archivists’ Toolkit™. The experimental workflow being tested at the ICLTT is an attempt to capture detailed metadata for a comparatively large collection of digitised periodicals and other collective publications such as yearbooks, readers, commemorative publications, almanacs, and anthologies. While all higher-level digital objects in the corpus were furnished with metadata from the beginning of the digitisation process, the current experiment is designed to enrich this data to more fully describe the contents of the material at hand. To achieve this end, the department’s standard tools were adapted, which had the added benefit of keeping software production costs at a minimum. While in earlier experiments of our group of researchers (metadata creators) created the TEI header for each text division manually, we have been trying to approach the problem by exploiting the contents section of the digitised issues and/or other secondary sources, which has resulted in a tangible acceleration of the process. Together with collecting basic data such as author, title, publication date, and creation date, the project classifies each division with a type of texts and topics, the latter using the standard Dewey Decimal Classification (version 22, German) with supplementary keywords. This paper discusses a number of issues concerning the quality and type of resulting data. It also touches upon the issue of automation and at what points in the process human intervention is indispensible. Particular attention is directed at the software module for creating TEI headers.

Constructing the matrix

As part of our ‘toolkit’ for analysing an extraterrestrial signal, the facility for calculating structural affinity to known phenomena must be part of our core capabilities. Without such a resource, we risk compromising our potential for detection and decipherment or at least causing significant delay in the process.To create such a repository for assessing structural affinity, all known systems (language parameters) need to be structurally analysed to ‘place’ their ‘system’ within a relational communication matrix. This will need to include all known variants of language structure, whether ‘living’ (in current use) or ancient; this must also include endeavours to incorporate yet undeciphered scripts and non-human communication, to provide as complete a picture as possible. In creating such a relational matrix, post-detection decipherment will be assisted by a structural ‘map’ that will have the potential for ‘placing’ an alien communication with its nearest known ‘neighbour’, to assist subsequent categorisation of basic parameters as a precursor to decipherment.‘Universal’ attributes and behavioural characteristics of known communication structure will form a range of templates (Elliott, 2001 [1] and Elliott et al., 2002 [2]), to support and optimise our attempt at categorising and deciphering the content of an extraterrestrial signal. Detection of the hierarchical layers, which comprise intelligent, complex communication, will then form a matrix of calculations that will ultimately score affinity through a relational matrix of structural comparison. In this paper we develop the rationales and demonstrate functionality with initial test results.